You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Ju Bo Liu

Chief Executive Officer at Novotek Pharmaceuticals Ltd.
In The News
Career History
Boards & Committees

Ju Bo Liu

Chief Executive Officer at Novotek Pharmaceuticals Ltd.


45 (Born 1973)
Notable Companies
Novotek Medicinal Technology Development Co., Ltd.

Novotek Pharmaceuticals Ltd.
Board Seats
Number of Relationships
This person is connected to 51 people.

Relationships See Details

Chief Financial Officer & Member-Management Board at Bioton SA

Chairman & Chief Executive Officer at SciGen Ltd.

Non-Independent Non-Executive Director at SciGen Ltd.

Former Director-Business Development at PT Capsugel Indonesia

Senior Vice President & Company Secretary at SciGen Ltd.

Co-Founder at Goldmark Plastic Compounds, Inc.

Director-Foreign Markets at Bioton SA

Former Director at SciGen Ltd.

Former Investment Manager at Phoenix Pharma Polska SP zoo

Former President at Prokom Software SA
See 41 more listings with RelSci Professional.

In The News See More

PR Newswire
May 4, 2017

Paths to Ju Bo Liu

Ju Bo Liu
Connections via Relationship Science
Ju Bo Liu
Sync your contacts to see how you can connect with Ju Bo Liu.

Educational Background

Class of 2006 
Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.
Class of 1997 

Career History

Chief Executive Officer
2009 - Current
Chief Executive Officer
NovoTek Pharmaceuticals Ltd. is a Hongkongese company that manufactures pharmaceutical products. The firm was founded by Ju Bo Liu, who is currently the CEO of the company.
Director-Marketing & Regulatory Affairs
1997 - 2001

Boards & Committees

Corporate Boards ▾
Non-Executive Director
2017 - Current
SciGen Ltd. is a biopharmaceutical company which engages in the development, manufacturing and markets of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China and Others. The Singapore segment comprises of principally corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and China segment deals with sales and marketing activities. The China segment includes regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.
Chairman, Supervisory Board
BIOTON SA engages in the manufacture and production of medicines and pharmaceutical substances. It offers oral hypoglycemic drug, foot cream and human insulin. It operates through the following segment: BIOTON S.A. and BIOTON MARKETING AGENCY Sp. z o.o.; SciGen Ltd Group; BioPartners Holding AG Group; MJ BioPharm Prv Ltd; Fisiopharma S.r.l. and Pharmatex S.r.l.; Copernicus Sp. z o.o.; BIOLEK Sp. z o.o. Group; BIOTON International GmbH (former name Actavis BIOTON GmbH), and MJ BIOTON Life Sciences Ltd. The company was founded on August 24, 1989 and is headquartered in Warsaw, Poland.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.